title: Disability progression in relapsing MS is more than just lesions: The lesson of fingolimod.
authors.affiliation: Mellen Center for Multiple Sclerosis, Cleveland Clinic, USA foxr@ccf.org.
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Fox
mesh_terms: D001921:Brain / Q000473:pathology*; D004185:Disability Evaluation; D005260:Female; D000068876:Fingolimod Hydrochloride / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*
chemical_list: D007166:Immunosuppressive Agents; D000068876:Fingolimod Hydrochloride